90 related articles for article (PubMed ID: 18558292)
1. Founder effect of the BRCA1 5382insC mutation in Brazilian patients with hereditary breast ovary cancer syndrome.
da Costa EC; Vargas FR; Moreira AS; Lourenço JJ; Caleffi M; Ashton-Prolla P; Martins Moreira MA
Cancer Genet Cytogenet; 2008 Jul; 184(1):62-6. PubMed ID: 18558292
[TBL] [Abstract][Full Text] [Related]
2. Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer.
Baudi F; Quaresima B; Grandinetti C; Cuda G; Faniello C; Tassone P; Barbieri V; Bisegna R; Ricevuto E; Conforti S; Viel A; Marchetti P; Ficorella C; Radice P; Costanzo F; Venuta S
Hum Mutat; 2001 Aug; 18(2):163-4. PubMed ID: 11462242
[TBL] [Abstract][Full Text] [Related]
3. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
4. BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer.
Thomassen M; Hansen TV; Borg A; Lianee HT; Wikman F; Pedersen IS; Bisgaard ML; Nielsen FC; Kruse TA; Gerdes AM
Acta Oncol; 2008; 47(4):772-7. PubMed ID: 18465347
[TBL] [Abstract][Full Text] [Related]
5. High frequency of BRCA1 5382insC mutation in Russian breast cancer patients.
Sokolenko AP; Mitiushkina NV; Buslov KG; Bit-Sava EM; Iyevleva AG; Chekmariova EV; Kuligina ESh; Ulibina YM; Rozanov ME; Suspitsin EN; Matsko DE; Chagunava OL; Trofimov DY; Devilee P; Cornelisse C; Togo AV; Semiglazov VF; Imyanitov EN
Eur J Cancer; 2006 Jul; 42(10):1380-4. PubMed ID: 16737811
[TBL] [Abstract][Full Text] [Related]
6. Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation?
Russo A; Calò V; Bruno L; Schirò V; Agnese V; Cascio S; Foddai E; Fanale D; Rizzo S; Di Gaudio F; Gulotta E; Surmacz E; Di Fede G; Bazan V
Breast Cancer Res Treat; 2009 Jan; 113(1):67-70. PubMed ID: 18228134
[TBL] [Abstract][Full Text] [Related]
7. The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript.
Vega A; Campos B; Bressac-De-Paillerets B; Bond PM; Janin N; Douglas FS; Domènech M; Baena M; Pericay C; Alonso C; Carracedo A; Baiget M; Diez O
Hum Mutat; 2001 Jun; 17(6):520-1. PubMed ID: 11385711
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 disease-associated haplotypes in Singapore Malay women with early-onset breast/ovarian cancer.
Ali AB; Iau PT; Putti TC; Sng JH
Breast Cancer Res Treat; 2007 Sep; 104(3):351-3. PubMed ID: 17406974
[No Abstract] [Full Text] [Related]
9. Novel and common BRCA1 mutations in familial breast/ovarian cancer patients from Lithuania.
Janavicius R; Pepalyte I; Kucinskas V
Breast Cancer Res Treat; 2009 Sep; 117(2):467-9. PubMed ID: 18763032
[No Abstract] [Full Text] [Related]
10. Haplotype analysis of the internationally distributed BRCA1 c.3331_3334delCAAG founder mutation reveals a common ancestral origin in Iberia.
Tuazon AMA; Lott P; Bohórquez M; Benavides J; Ramirez C; Criollo A; Estrada-Florez A; Mateus G; Velez A; Carmona J; Olaya J; Garcia E; Polanco-Echeverry G; Stultz J; Alvarez C; Tapia T; Ashton-Prolla P; ; Vega A; Lazaro C; Tornero E; Martinez-Bouzas C; Infante M; De La Hoya M; Diez O; Browning BL; ; Rannala B; Teixeira MR; Carvallo P; Echeverry M; Carvajal-Carmona LG
Breast Cancer Res; 2020 Oct; 22(1):108. PubMed ID: 33087180
[TBL] [Abstract][Full Text] [Related]
11. Absence of the BRCA1 del (exons 9-12) mutation in breast/ovarian cancer families outside of Mexican Hispanics.
Torres D; Rashid MU; ; Seidel-Renkert A; Weitzel JN; Briceno I; Hamann U
Breast Cancer Res Treat; 2009 Oct; 117(3):679-81. PubMed ID: 19333752
[No Abstract] [Full Text] [Related]
12. BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark.
Soegaard M; Kjaer SK; Cox M; Wozniak E; Høgdall E; Høgdall C; Blaakaer J; Jacobs IJ; Gayther SA; Ramus SJ
Clin Cancer Res; 2008 Jun; 14(12):3761-7. PubMed ID: 18559594
[TBL] [Abstract][Full Text] [Related]
13. Molecular and in silico analysis of BRCA1 and BRCA2 variants.
Tommasi S; Pilato B; Pinto R; Monaco A; Bruno M; Campana M; Digennaro M; Schittulli F; Lacalamita R; Paradiso A
Mutat Res; 2008 Sep; 644(1-2):64-70. PubMed ID: 18694767
[TBL] [Abstract][Full Text] [Related]
14. The p53 Arg72Pro and Ins16bp polymorphisms and their haplotypes are not associated with breast cancer risk in BRCA-mutation negative familial cases.
De Vecchi G; Verderio P; Pizzamiglio S; Manoukian S; Bernard L; Pensotti V; Volorio S; Ravagnani F; Radice P; Peterlongo P
Cancer Detect Prev; 2008; 32(2):140-3. PubMed ID: 18640791
[TBL] [Abstract][Full Text] [Related]
15. On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations.
Hamel N; Feng BJ; Foretova L; Stoppa-Lyonnet D; Narod SA; Imyanitov E; Sinilnikova O; Tihomirova L; Lubinski J; Gronwald J; Gorski B; Hansen Tv; Nielsen FC; Thomassen M; Yannoukakos D; Konstantopoulou I; Zajac V; Ciernikova S; Couch FJ; Greenwood CM; Goldgar DE; Foulkes WD
Eur J Hum Genet; 2011 Mar; 19(3):300-6. PubMed ID: 21119707
[TBL] [Abstract][Full Text] [Related]
16. BRCA1:185delAG found in the San Luis Valley probably originated in a Jewish founder.
Makriyianni I; Hamel N; Ward S; Foulkes WD; Graw S
J Med Genet; 2005 May; 42(5):e27. PubMed ID: 15863659
[No Abstract] [Full Text] [Related]
17. Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study.
Lee E; Ma H; McKean-Cowdin R; Van Den Berg D; Bernstein L; Henderson BE; Ursin G
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3170-8. PubMed ID: 18990759
[TBL] [Abstract][Full Text] [Related]
18. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.
Fortuny D; Balmaña J; Graña B; Torres A; Ramón y Cajal T; Darder E; Gadea N; Velasco A; López C; Sanz J; Alonso C; Brunet J
Hum Reprod; 2009 Apr; 24(4):1000-6. PubMed ID: 19112076
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 5382insC mutation in sporadic and familial breast and ovarian carcinoma in Scotland.
Mullen P; Miller WR; Mackay J; Fitzpatrick DR; Langdon SP; Warner JP
Br J Cancer; 1997; 75(9):1377-80. PubMed ID: 9155062
[TBL] [Abstract][Full Text] [Related]
20. A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testing.
Dørum A; Møller P; Kamsteeg EJ; Scheffer H; Burton M; Heimdal KR; Maehle LO; Hovig E; Tropé CG; van der Hout AH; van der Meulen MA; Buys CH; te Meerman GJ
Eur J Cancer; 1997 Dec; 33(14):2390-2. PubMed ID: 9616287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
